Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010).

MLA

Kemp, David E., et al. “Metabolic Syndrome and Its Potential Effect on Treatment Response to Aripiprazole: A Post Hoc Analysis of the Stabilization Phase of a Long-Term, Double-Blind Study in Patients with Bipolar Disorder (CN138-010).” Journal of Clinical Psychopharmacology, vol. 30, no. 5, Oct. 2010, pp. 631–34. EBSCOhost, https://doi.org/10.1097/JCP.0b013e3181f0569f.

APA

Kemp, D. E., Eudicone, J. M., McQuade, R. D., Chambers, J. S., & Baker, R. A. (2010). Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010). Journal of Clinical Psychopharmacology, 30(5), 631–634. https://doi.org/10.1097/JCP.0b013e3181f0569f

Chicago

Kemp, David E, James M Eudicone, Robert D McQuade, Jessie S Chambers, and Ross A Baker. 2010. “Metabolic Syndrome and Its Potential Effect on Treatment Response to Aripiprazole: A Post Hoc Analysis of the Stabilization Phase of a Long-Term, Double-Blind Study in Patients with Bipolar Disorder (CN138-010).” Journal of Clinical Psychopharmacology 30 (5): 631–34. doi:10.1097/JCP.0b013e3181f0569f.